Stemline therapeutics switzerland gmbh
網頁Le représentant européen désigné de Stemline Therapeutics Inc. et de Stemline Therapeutics Switzerland GmbH conformément à l'article 27 du RGPD est A. Menarini Industrie Farmaceutiche Riunite S.r.l., situé à Florence, Via Sette Santi 1. Le délégué 網頁Stemline Therapeutics Switzerland GmbH Grafenaustrasse 3 6300 Zug Schweiz Tel. +41 41 710 01 16 www.stemline.com Datenschutzerklärung gemäß Artikel 13 und 14 der …
Stemline therapeutics switzerland gmbh
Did you know?
網頁Stemline is a commercial-stage biopharmaceutical company committed to applying our scientific leadership and commercial expertise to transform the lives of patients with … 網頁2024年4月11日 · Selumetinib, an oral selective mitogen-activated extracellular signal-regulated kinase (MEK) 1/2 inhibitor, is approved for the treatment of pediatric patients ≥ 2 years old with neurofibromatosis type 1 and symptomatic inoperable …
網頁2024年6月10日 · Menarini acquired Stemline for an upfront payment of $11.50 per share in cash and one non-tradeable Contingent Value Right (CVR) that will entitle each holder to an additional $1.00 per share in ... 網頁Ob Praktikum, Direkteinstieg oder Berufserfahrene – unser Karriereportal bietet unterschiedliche Einstiegsmöglichkeiten. Hier geht’s zu Ihrer Bewerbung:…
網頁Passionate and very dynamic person, my talent is to build bridges between various stakeholders by using all communication channels at their bests. With 10+ years of experience with BigPharma companies, my … 網頁Stemline Therapeutics Switzerland GmbH is a Limited Liability Company based in Zug, in the canton of Zug, founded in 2024. Its identification number UID is CHE-166.416.225. It is active in "wholesale of chemical products". Currently, the people holding decision-making roles are Stemline Therapeutics B.V. (75597209) (Partner), David George ...
網頁2024年4月26日 · EUROPEA.Market AnalysisCurrent & Future AnalysisChanging Demographics to Propel Market GrowthTable 22: European Population By Age Group (2013, 2024 & 2040): Percentage Share Breakdown of Age ...
網頁Ahmed is the Chief Commercial Officer for Stemline Therapeutics. He joined Stemline in September 2024 and has more than 25 years of international biotechnology and … recent business ethical scandals網頁Find company research, competitor information, contact details & financial data for Stemline Therapeutics Switzerland GmbH of Zug, ZUG. Get the latest business insights from … recent business scandals snpmar23網頁Free and open company data on Switzerland company Stemline Therapeutics Switzerland GmbH (company number 1409641), Grafenaustrasse, 3, Zug, 6300 Company Number … uniworld holidays網頁Funding. Stemline Therapeutics has raised a total of $107.1M in funding over 5 rounds. Their latest funding was raised on Jan 15, 2024 from a Post-IPO Equity round. Stemline Therapeutics is registered under the ticker NASDAQ:STML . Their stock opened with $10.00 in its Jan 29, 2013 IPO. uniworld holiday cruises網頁Stemline News & Media. Stemline is part of the Menarini Group, a leading international pharmaceutical and diagnostics company, with a turnover of over $4 billion and over … Stemline Therapeutics, Inc. 750 Lexington Avenue, 11th Floor New York, NY 10022 … recent business scandals 2023網頁Free and open company data on Switzerland company Stemline Therapeutics Switzerland GmbH (company number 1409641), Grafenaustrasse, 3, Zug, 6300 Company Number 1409641 Status Aktive Company Type Gesellschaft mit beschränkter Haftung Jurisdiction recent business tort cases 2021網頁2024年5月4日 · Stemline Contacts Investor Relations Peter McDonald Stemline Therapeutics, Inc. 646-502-2307 Email: [email protected] Media Andy Brimmer / Scott Bisang Joele Frank, Wilkinson Brimmer Katcher ... uniworld holland and belgium